29 Oct Control HAE types I and II with a pill instead of injections!
No More Needles to Prevent HAE Attacks? We need you to help us find out.
Right now, patients are being enrolled in the APeX-S study, a worldwide clinical research study to investigate the long-term safety of an investigational oral medication to prevent hereditary angioedema (HAE) attacks.
If you have Type I or II HAE, have used androgen therapy, and are interested in learning about an oral medication that could become an alternative to injections or infusions to prevent attacks, then see if you qualify.
You can find additional information about APeX-S at
Seattle Allergy & Asthma Research Institute
9725 Third Ave. NE, Suite 500
Seattle, WA 98115
Type 1 and Type 2 HAE
12 years and older
(206) 525-5520 x1181
Additional Study Details
Full Study Title
HAE Trial BCX7353
Accepts Healthy Volunteers?
Seattle Allergy and Asthma Research Institute
9725 3rd Ave NE STE 500
Seattle, Washington 98115